Abstract
Cytokine release syndrome and immune effector cell‑associated neurotoxicity syndrome in a melanoma patient treated with adjuvant pembrolizumab
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have